Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Bioactive food and exercise in chronic kidney disease: Targeting the mitochondria.

Mafra D, Gidlund EK, Borges NA, Magliano DC, Lindholm B, Stenvinkel P, von Walden F.

Eur J Clin Invest. 2018 Nov;48(11):e13020. doi: 10.1111/eci.13020. Epub 2018 Sep 16. Review.

PMID:
30144313
2.

Mitochondrial bioenergetics, redox state, dynamics and turnover alterations in renal mass reduction models of chronic kidney diseases and their possible implications in the progression of this illness.

Aparicio-Trejo OE, Tapia E, Sánchez-Lozada LG, Pedraza-Chaverri J.

Pharmacol Res. 2018 Sep;135:1-11. doi: 10.1016/j.phrs.2018.07.015. Epub 2018 Jul 17. Review.

PMID:
30030169
4.

Chronic kidney disease and acquired mitochondrial myopathy.

Rao M, Jaber BL, Balakrishnan VS.

Curr Opin Nephrol Hypertens. 2018 Mar;27(2):113-120. doi: 10.1097/MNH.0000000000000393. Review.

PMID:
29266014
5.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
6.

AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.

Nishikawa M, Ishimori N, Takada S, Saito A, Kadoguchi T, Furihata T, Fukushima A, Matsushima S, Yokota T, Kinugawa S, Tsutsui H.

Nephrol Dial Transplant. 2015 Jun;30(6):934-42. doi: 10.1093/ndt/gfv103. Epub 2015 Apr 15.

PMID:
25878055
7.

Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease.

Gamboa JL, Billings FT 4th, Bojanowski MT, Gilliam LA, Yu C, Roshanravan B, Roberts LJ 2nd, Himmelfarb J, Ikizler TA, Brown NJ.

Physiol Rep. 2016 May;4(9). pii: e12780. doi: 10.14814/phy2.12780.

8.

Transforming growth factor-β, bioenergetics, and mitochondria in renal disease.

Casalena G, Daehn I, Bottinger E.

Semin Nephrol. 2012 May;32(3):295-303. doi: 10.1016/j.semnephrol.2012.04.009. Review.

9.

Bioenergetics and mitochondrial dysfunction in aging: recent insights for a therapeutical approach.

Romano AD, Greco E, Vendemiale G, Serviddio G.

Curr Pharm Des. 2014;20(18):2978-92. Review.

PMID:
24079772
10.

Mitochondria: a hub of redox activities and cellular distress control.

Kakkar P, Singh BK.

Mol Cell Biochem. 2007 Nov;305(1-2):235-53. Epub 2007 Jun 12. Review.

PMID:
17562131
11.

Melatonin-mitochondria interplay in health and disease.

Acuña Castroviejo D, López LC, Escames G, López A, García JA, Reiter RJ.

Curr Top Med Chem. 2011;11(2):221-40. Review.

PMID:
21244359
12.

Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart Disease.

Sverdlov AL, Elezaby A, Qin F, Behring JB, Luptak I, Calamaras TD, Siwik DA, Miller EJ, Liesa M, Shirihai OS, Pimentel DR, Cohen RA, Bachschmid MM, Colucci WS.

J Am Heart Assoc. 2016 Jan 11;5(1). pii: e002555. doi: 10.1161/JAHA.115.002555.

13.

Mitochondria: a central target for sex differences in pathologies.

Ventura-Clapier R, Moulin M, Piquereau J, Lemaire C, Mericskay M, Veksler V, Garnier A.

Clin Sci (Lond). 2017 May 1;131(9):803-822. doi: 10.1042/CS20160485. Review.

PMID:
28424375
14.

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.

Sas K, Szabó E, Vécsei L.

Molecules. 2018 Jan 17;23(1). pii: E191. doi: 10.3390/molecules23010191. Review.

15.

Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Lindblom R, Higgins G, Coughlan M, de Haan JB.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):134-56. doi: 10.1900/RDS.2015.12.134. Epub 2015 Aug 10. Review.

16.

The Emerging Role of Mitochondrial Targeting in Kidney Disease.

Eirin A, Lerman A, Lerman LO.

Handb Exp Pharmacol. 2017;240:229-250. doi: 10.1007/164_2016_6. Review.

17.

Mitochondrial Dysfunction and Signaling in Diabetic Kidney Disease: Oxidative Stress and Beyond.

Flemming NB, Gallo LA, Forbes JM.

Semin Nephrol. 2018 Mar;38(2):101-110. doi: 10.1016/j.semnephrol.2018.01.001. Review.

PMID:
29602393
18.

[Mitochondria and oxidative stress participation in renal inflammatory process].

Manucha W.

Medicina (B Aires). 2014;74(3):254-8. Review. Spanish.

19.

Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.

Tanabe K, Tamura Y, Lanaspa MA, Miyazaki M, Suzuki N, Sato W, Maeshima Y, Schreiner GF, Villarreal FJ, Johnson RJ, Nakagawa T.

Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1264-74. doi: 10.1152/ajprenal.00227.2012. Epub 2012 Aug 29.

20.

Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease.

Gortan Cappellari G, Semolic A, Ruozi G, Vinci P, Guarnieri G, Bortolotti F, Barbetta D, Zanetti M, Giacca M, Barazzoni R.

FASEB J. 2017 Dec;31(12):5159-5171. doi: 10.1096/fj.201700126R. Epub 2017 Aug 4.

PMID:
28778977

Supplemental Content

Support Center